Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
Go back to Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 285.48 +6.04 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $279.44 | 52 Week High | $139.79 | |||
| Open | $283.35 | 52 Week Low | $82.07 | |||
| Day High | $288.46 | P/E | 663.91 | |||
| Day Low | $278.65 | EPS | $0.43 | |||
| Volume | 302,720 | |||||

